TY - JOUR
T1 - Hepatic glucose autoregulation
T2 - Responses to small, non-insulin-induced changes in arterial glucose
AU - Camacho, Raul C.
AU - Lacy, D. Brooks
AU - James, Freyja D.
AU - Coker, Robert H.
AU - Wasserman, David H.
PY - 2004/8
Y1 - 2004/8
N2 - The purpose of this study was to determine whether the sedentary dog is able to autoregulate glucose production (Ra) in response to non-insulin-induced changes (<20 mg/dl) in arterial glucose. Dogs had catheters implanted >16 days before study. Protocols consisted of basal (-30 to 0 min) and bilateral renal arterial phloridzin infusion (0-180 min) periods. Somatostatin was infused, and glucagon and insulin were replaced to basal levels. In one protocol (Phl ± Glc), glucose was allowed to fall from t = 0-90 min. This was followed by a period when glucose was infused to restore euglycemia (90-150 min) and a period when glucose was allowed to fall again (150-180 min). In a second protocol (EC), glucose was infused to compensate for the renal glucose loss due to phloridzin and maintain euglycemia from t = 0-180 min. Arterial insulin, glucagon, cortisol, and catecholamines remained at basal in both protocols. In Phl ± Glc, glucose fell by ∼20 mg/dl by t = 90 min with phloridzin infusion. Rα did not change from basal in Phl ± Glc despite the fall in glucose for the first 90 min. Ra was significantly suppressed with restoration of euglycemia from t = 90-150 min (P < 0.05) and returned to basal when glucose was allowed to fall from t = 150-180 min. Ra did not change from basal in EC. In conclusion, the liver autoregulates Ra in response to small changes in glucose independently of changes in pancreatic hormones at rest. However, the liver of the resting dog is more sensitive to a small increment, rather than decrement, in arterial glucose.
AB - The purpose of this study was to determine whether the sedentary dog is able to autoregulate glucose production (Ra) in response to non-insulin-induced changes (<20 mg/dl) in arterial glucose. Dogs had catheters implanted >16 days before study. Protocols consisted of basal (-30 to 0 min) and bilateral renal arterial phloridzin infusion (0-180 min) periods. Somatostatin was infused, and glucagon and insulin were replaced to basal levels. In one protocol (Phl ± Glc), glucose was allowed to fall from t = 0-90 min. This was followed by a period when glucose was infused to restore euglycemia (90-150 min) and a period when glucose was allowed to fall again (150-180 min). In a second protocol (EC), glucose was infused to compensate for the renal glucose loss due to phloridzin and maintain euglycemia from t = 0-180 min. Arterial insulin, glucagon, cortisol, and catecholamines remained at basal in both protocols. In Phl ± Glc, glucose fell by ∼20 mg/dl by t = 90 min with phloridzin infusion. Rα did not change from basal in Phl ± Glc despite the fall in glucose for the first 90 min. Ra was significantly suppressed with restoration of euglycemia from t = 90-150 min (P < 0.05) and returned to basal when glucose was allowed to fall from t = 150-180 min. Ra did not change from basal in EC. In conclusion, the liver autoregulates Ra in response to small changes in glucose independently of changes in pancreatic hormones at rest. However, the liver of the resting dog is more sensitive to a small increment, rather than decrement, in arterial glucose.
KW - Glucose turnover
KW - Phloridzin
UR - https://www.scopus.com/pages/publications/3242728663
U2 - 10.1152/ajpendo.00040.2004
DO - 10.1152/ajpendo.00040.2004
M3 - Article
C2 - 15053988
AN - SCOPUS:3242728663
SN - 0193-1849
VL - 287
SP - E269-E274
JO - American Journal of Physiology - Endocrinology and Metabolism
JF - American Journal of Physiology - Endocrinology and Metabolism
IS - 2 50-2
ER -